Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1561-1567

  West, D ^a   Reddin, K ^a   Matheson, M ^a   Heath, R ^a   Funnell, S ^a   Hudson, M ^a   Robinson, A ^a   Gorringe, A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEISSERIA MENINGITIDIS TRANSFERRIN BINDING PROTEIN A; RECOMBINANT PROTEIN; TRANSFERRIN BINDING PROTEIN A; TRANSFERRIN BINDING PROTEIN B; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; GENE OVEREXPRESSION; MENINGOCOCCOSIS; MOLECULAR WEIGHT; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM BACTERICIDAL ACTIVITY; STRAIN DIFFERENCE; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; CARRIER PROTEINS; CLONING, MOLECULAR; ESCHERICHIA COLI; IRON-BINDING PROTEINS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; NEISSERIA MENINGITIDIS; PERITONEAL DISEASES; TRANSFERRIN-BINDING PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0035119318     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1561-1567.2001     Document Type: Article

References (46)

1. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA
2. Immune responses in humans and animals to meningococcal transferrin-binding proteins: Implications for vaccine design
3. Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization
4. Meningococcal disease falls in vaccine recipients
5. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults
6. Effect of outer membrane vesicle against group B meningococcal disease in Norway
7. Efficacy, safety and immunogenicity of a meningococcal group B (15: P1.3) outer membrane protein vaccine in Iquique, Chile
8. Transferrin-binding protein B isolated from Neisseria meningitidis discriminates between apo and diferric human transferrin
9. A dynamic model of the meningococcal transferrin receptor
10. Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein
11. - cloning vectors I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing
12. A simple and rapid method for the preparation of gram-negative bacterial genomic DNA
13. The transferrin receptor expressed by gonococcal FA1090 is required for the experimental infection of human male volunteers
14. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals
15. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil
16. In vivo human response to transferrin-binding protein 2 and other iron-regulated proteins of Neisseria meningitidis
17. Purification of the Neisseria meningitidis transferrin binding protein-2 (TBP2) to homogeneity using column chromotography
18. Reliability of laboratory models in the analysis of TBP2 and other meningococcal antigens
19. Human immunity to the meningococcus. I. The role of humoral antibodies
20. Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis
21. Human antibody response to meningococcal transferrin binding proteins: Evidence for vaccine potential
22. Bacterial transferrin and lactoferrin receptors
23. Iron-controlled infection with Neisseria meningitidis in mice
24. Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis
25. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2
26. Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli
27. Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes
28. Frequent interspecific genetic exchange between commensal neisseriae and Neisseria meningitidis
29. Evaluation of transferrin binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines
30. Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model
31. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine
32. Diversity of the transferrin-binding protein Tbp2 of Neisseria meningitidis
33. Evidence for autoimmune antibodies directed against embryonic neural adhesion molecules (N-CAM) in patients with group B meningitis
34. Sequence analysis of the structural tbpA gene: Protein topology and variable regions within neisserial receptors for transferrin iron acquisition
35. Neisseria meningitidis transferrin-binding protein 1 expressed in Escherichia coli is surface exposed and binds human transferrin
36. Blocking of iron uptake by monoclonal antibodies specific for the Neisseria meningitidis transferrin-binding protein 2
37. Analysis of TbpA and TbpB functionality in defective mutants of Neisseria meningitidis
38. Identification of vaccine candidates against serogroup B meningococcus by whole-genuine sequencing
39. Protective capacity of the Pasturella haemolytica transferrin-binding proteins TbpA and TbpB in cattle
40. Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features
41. Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes
42. Heterogeneity of tbpB, the transferrin binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex
43. Identification and characterization of the transferrin receptor from Neisseria meningitidis
44. Vaccine against group B Neisseria meningitidis: Protection trial and mass vaccination results in Cuba
45. Expression of a high-affinity mechanism for acquisition of transferrin iron by Neisseria meningitidis
46. Periplasmic superoxide dismutase in meningococcal pathogenicity